In This Section

Spotlight on Clinical Trials

The titles of the clinical trial abstracts are now available on the online itinerary planner. The text of these abstracts will be posted to the planner on Friday, April 5.

Clinical Trial Abstract Sessions

Key Dates: Abstract Status Notification and Embargo Release

  • February 6, 2024: Final Results and Conclusions Due for Clinical Trial Placeholder Abstracts (5 p.m. ET)
  • February 12, 2024: Status Notifications and Scheduling Information Sent for Clinical Trials Abstracts (submitted for January 8 deadline)
  • March 5, 2024: Titles of Clinical Trial Abstracts Posted to Online Itinerary Planner (4:30 p.m. ET)
  • April 5, 2024: Text of Clinical Trial Abstracts Posted to Online Itinerary Planner (3 p.m. ET)

Clinical Trial Presentation Opportunities

  • Numerous and unique oral presentation opportunities, including:
    • Four Clinical Trials Plenary Sessions offering companion presentations discussing the science behind the trials presented
    • Three Clinical Trials Minisymposia
  • Poster presentations
  • Opportunities for extensive national media coverage through the AACR press program
  • Opportunities to publish a manuscript in one of the AACR’s highly regarded journals, including possible simultaneous publication with your abstract presentation
    • Review the FAQ relating to simultaneous publication in the AACR Journals for more information
    • Contact [email protected] with any questions
  • No restrictions on presenters if the presentation is CME-compliant

EMBARGO POLICY AND ONLINE PUBLICATION OF ABSTRACTS

  • In accordance with the AACR’s embargo policy, the content of abstracts must be kept confidential until they are made publicly available:  
  • The titles and authors of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner no earlier than 4:30 p.m. U.S. ET on Tuesday, March 5, 2024. (Abstract Texts are Embargoed until 12:00 p.m. U.S. PT on Friday, April 5, 2024.) 
  • The full text of the Clinical Trial and Late-Breaking Abstracts will be posted to the AACR Online Itinerary Planner and the Meeting App no earlier than 12:00 p.m. U.S. PT on Friday, April 5, 2024, except those abstracts that are selected for inclusion in the official AACR press program. Abstracts that are featured in the official AACR press program will be made publicly available at the date and time of presentation, either at the meeting or an official AACR press conference.  
  • In previous years, abstracts accepted for presentation at the AACR Annual Meeting were published in an online-only Proceedings supplement to the AACR journal Cancer Research after the conclusion of the meeting. For the AACR Annual Meeting 2024, the Proceedings supplement will be published prior to the meeting in two parts. Part 1 of the online Proceedings (regular abstracts) will be published on Friday, March 22, and Part 2 (clinical trials and late-breaking abstracts) will be published on Friday, April 5. Revised Proceedings supplements containing the full text of embargoed abstracts as well as any late change will be published in Cancer Research approximately one month after the meeting.